Vaccine World Summit India 2013 印度全球疫苗高峰会2013
基本信息
会议名称: Vaccine World Summit India 2013 印度全球疫苗高峰会2013
会议时间: 2013年3月5日至2013年3月7日
会议地点: 印度 . 浦那,Westin Pune Koregaon Park
主办单位: IMAPAC
官方网站: http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013
会议信息
行业领域: 疫苗产业、生物制药
会议类型: 高峰会、行业会议、研讨会
会议主题: 探索疫苗生命周期各阶段的合作机会,从基础研究到生产、许可等各个方面
详细信息
早期折扣截止日期: 2013年1月31日
联系信息:
邮件:info@imapac.com
电话:+65 6493 2097
会议演讲者
Dr Suresh Jadhav, Executive Director, Serum Institute, India
Dr Rajiv Indravadan Modi, Director/Managing Director, Cadila Pharmaceuticals, India
Dr Inderjit Singh Sarao, Associate Director, Merck, USA
Dr James F. Young, Chairman, Novavax, USA
Dr Harish Iyer, CEO, Shantha Biotechnics, India
Dr Norman Baylor, Advisor, PATH MVI Vaccine Science Portfolio Advisory Council (VSPAC), USA
Dr Ranga Iyer, Advisor, Indian Health Progress & Global Pharma Associations, India
Dr Raj Shankar Ghosh, Technical Director, PATH , India
Dr Stanley Erck, President and CEO, Novavax, USA
Dr Anand Kumar, Deputy Managing Director, Indian Immunologicals, India
Dr V. Krishna Mohan, Executive Director, Bharat Biotech International, India
Dr SD Ravetkar, Executive Director, Serum Institute, India
Dr Reinhard Glueck, Chief Scientific Officer, Zydus Cadila, India
Dr Shirshendu Mukherjee, Senior Strategic Advisor, Wellcome Trust, India
Dr Davinder Gill, Chief Executive Officer, MSD Wellcome Trust Hilleman Laboratories, India
Dr Ramesh S. Paranjape, Director, National AIDS Research Institute, India
Dr Vipin Vashishtha, Convener, Indian Academy of Pediatrics - Committee on Immunization, India
Helen Yang, Business Development Director, Sinovac Biotech, China
Dr Sanjay Singh, Chairman, Gennova Biopharma, India
Dr Jacqui Shea, General Manager, Oxford-Emergent Tuberculosis Consortium, UK
Abdul Muktadir, Managing Director, Incepta, Bangladesh
Dr Rajendra Jani, Senior Vice President of Clinical R&D, Cadila Healthcare, India
Dr Gregory Glenn, Senior VP and CMO, Novovax
Dr Ashish Bavdekar, President, IAP - Gastroenterology Chapter
Ashish Kenneth Kelley, Co-Founder, CEO, Executive Chairman, PaxVax
Prof T Jacob John, Virologist, Christian Medical College in Vellore, WHO Committee Global Polio Eradication, India
Dr Shailesh Mehta, Medical Director of Clinical R&D (Medical Affairs Biologics - South Asia),GSK
Dr Ramesh Matur, General Manager of R&D, Indian Immunologicals
Dr Sudhakar Konda, Vice President, One Stream R&D (Panacea)
Dr Steve Whitehead, Head of Dengue Project, Laboratory of Infectious Diseases of NIH
Dr Subhra Chakrabarti, Head of Manufacturing Technology, Shantha Biotechnics
Dr Rakesh Sinha, General Manager and Project Director of JE Vaccine, Biological E.
Dr Nathelie Garcon, Vice President and Head of Global Adjuvant Centre for Vaccine Development,GSK Biologicals
Dr Anuj Walia, Regional Director of Medical Affairs, MSD Pharmaceuticals
Dr Alfred Luitjens, Early Stage Development Leader for the Inactivated Polio Project and Senior Scientist, Crucell
分享到